About Steven M Smith
Steven Smith is an Assistant Professor in the Department of Pharmacotherapy and Translational Research and serves as Associate Director for the UF Center for Integrative Cardiovascular and Metabolic Diseases.
He received his PharmD degree from the University of Florida College of Pharmacy. He then completed a PGY-1 residency at the North Florida/South Georgia Veterans Health System in Gainesville, FL. After his residency, Dr. Smith completed a postdoctoral fellowship in Family Medicine at UF with Dr. John Gums. During his fellowship, Dr. Smith participated in the Advanced Postgraduate Program in Clinical Investigation (APPCI) and concurrently completed the requirements for a Master of Public Health through the College of Public Health and Health Professions. Dr. Smith then joined the faculty at the University of Colorado in 2011. He returned to the University of Florida in 2014.
Dr. Smith’s research is in the area of cardiovascular pharmacotherapy and hypertension and is funded by the National Heart, Lung, and Blood Institute of the National Institutes of Health. He is a member of the American Heart Association, American College of Cardiology, American College of Clinical Pharmacy, the American Association of Colleges of Pharmacy and the International Society for Pharmacoepidemiology. He also serves on the Examination Committee for the American Society of Hypertension Specialists’ Program (ASHSP) Certified Hypertension Clinician program and as a programming committee member for the annual American Heart Association Hypertension Council scientific sessions.
Dr. Smith also co-directs the UF Family Medicine Pharmacy Fellowship (https://ptr.pharmacy.ufl.edu/uf-family-medicine-pharmacy-fellowship/).
Dr. Smith teaches Pharmacy & Population Health in the first year of the UF Pharm.D. curriculum.
Honors & Awards
Board-Certified Pharmacotherapy SpecialistBoard of Pharmaceutical Specialties
Certified Hypertension ClinicianAmerican Hypertension Specialist Certification Program
Dr. Smith’s research lab focuses on understanding and improving use of cardiovascular-related drug therapy in the real world to reduce risk of major adverse outcomes at the population level. Hypertension and its treatment are the major area of focus, and Dr. Smith has particular expertise in the area of difficult-to-control, or ‘resistant’ hypertension.
His lab employs a variety of observational methodologic approaches and data sources, including EHR, administrative claims, and prospective cohort and randomized clinical trial data. Strong collaborations within the College of Pharmacy include with faculty and trainees in the Cardiovascular group of the Department of Pharmacotherapy and Translational Research, as well as with the Department of Pharmaceutical Outcomes and Policy and the Center for Drug Evaluation and Safety. Outside of the College, Dr. Smith’s group works closely with the Division of Cardiovascular Medicine and the Center for Integrative Cardiovascular and Metabolic Diseases, where Dr. Smith serves as Associate Director.
Current funding for the lab is through the National Heart, Lung and Blood Institute (NIH), and is focused on using integrated EHR and claims data to better understand what drives antihypertensive prescribing and effectiveness/safety issues with such drugs in the real world, and to use that information in developing predictive models for improving selection of initial antihypertensive therapy.